Dr. Eric Larsen Discusses Outcomes for AYA Patients With Acute Lymphoblastic Leukemia

Eric Larsen, MD, medical director of the Maine Children's Cancer Program, discusses a large phase III study that compared outcomes between adolescent and young adult (AYA) and younger patients with high-risk acute lymphoblastic leukemia (HR-ALL).

Find out more at http://www.onclive.com/onclive....-tv/Dr-Larsen-Discus

• Kategorija